In: Martin WR, ed. Drug addiction I. New York: Springer Verlag, 1977: 319-409. and play a role in the development of uremic coma (7) and defective platelet aggregation ) and Streptococcus tend to produce phenol from tyrosine, whereas anaerobic bacteria such as Clostridium and Bacteroides producep-cresol (10-13). These phenols are absorbed from intestine and normally excreted into urine. In uremia, renal clearance of the phenols is impaired, leading to accumulation of the phenols in the blood.
Phenol and p-Cresol Accumulated in Uremic Serum Measured by HPLC with Fluorescence Detection

Teshimitsu Niwa
We developed a simple and sensitive high-performance liquid chromatographic (HPLC) method that uses fluorescence as a detector for quantifying serum phenol and p-cresol in uremic patients on hemodialysis. Identification of phenol and p-cresol was confirmed by liquid chromatography/mass spectrometry. Because the HPLC method requires only simple extraction by ethyl acetate and does not require further steps such as derivatization, it is simple and rapid compared with gas chromatography or gas chromatography/mass spectrometry. Concentrations of phenol and p-cresol in uremic serum were significantly(p <0.01) higher than those in normal serum. Reduction rates of phenol and p-cresol by hemodialysis were lower than those of urea and creatinine, suggesting a proteinbinding property of phenol and p-cresol. This method will be useful for monitoring serum phenols in dialyzed patients as an index of hemodialysis adequacy.
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Phenol and p-cresol markedly accumulate
in the serum of undialyzed and dialyzed uremic patients (1) (2) (3) (4) (5) (6) and play a role in the development of uremic coma (7) and defective platelet aggregation ) and Streptococcus tend to produce phenol from tyrosine, whereas anaerobic bacteria such as Clostridium and Bacteroides producep-cresol (10) (11) (12) (13) . These phenols are absorbed from intestine and normally excreted into urine. In uremia, renal clearance of the phenols is impaired, leading to accumulation of the phenols in the blood.
The serum concentrations of phenol and p-cresol in uremic serum have been determined by using colorimetDepartment of Clinical Laboratory, Nagoya University Branch Hospital, 1-1-20, Daiko-minauni, Higashi-ku, Nagoya 461, Japan. 
Materials and Methods
Subjects
The study included 17 patients (10 men and 7 women) receiving hemodialysis for 4 h, three times per week. They had been undergoing periodic dialysis for 4.2 (SD 4.0) years (range 0.7-12.6 years). Their mean age was 57.4 (SD 11.1) years (range 34-69 years). Blood samples were taken before and after hemodialysis and allowed to clot. The control subjects were a group of 10 healthy subjects (6 men and 4 women).
'Nonstandard abbreviations:
LCIMS, liquid chromatography/ mass spectrometry; GC, gas chromatography; GC/MS, gas chroinatography/mass spectrometry; APCI, atmospheric-pressure Figure 2 shows the fluorescence excitation and emission spectra for phenol and p-cresol. 
P-Creed
The eluate was monitored by detection of fluorescence (excitation at 260 nm and emission at 305 nm). mass spectra for phenol and p-cresol showed more definite and more sensitive quasimolecular ions than did their positive-ion mass spectra.
All results are expressed as mean ± SD. Statistical analysis was done by using the Welch test.
Results
The calibration lines relating the concentrations (y) of phenol and p-cresol to their peak areas (x) were obtained from the HPLC chromatograms.
The correlation coefficients of the calibration lines for phenol (y = 5.07 x -0.26) and for p-cresol (y = 8.92 x -0.26) were 0.99993 and 0.99991, respectively. There were no interfering peaks in the HPLC chromatograms of the serum samples for quantification of phenol and p-cresol. The intraassay coefficients of variation (CVs) for phenol and p-cresol in a uremic serum sample were 4.0% and 5.3%, respectively, and those in a standard solution of 5 mgfL were 1.9% and 2.2%, respectively.
The interassay CVs for phenol and p-cresol in the uremic serum sample were 7.8% and 8.3%, respectively. The recoveries of phenol and p-cresol added into the uremic serum at a concentration of 5 mg/L were 103.8 ± 2.8% and 95.9 ± 9.7%, respectively. Figure 3 shows HPLC chromatograms of authentic phenol and p-cresol, an extract from uremic serum, and an extract from normal serum. The peaks of phenol and p-cresol in the uremic serum can be clearly recognized because there are no interfering peaks. The concentrations of phenol and p-cresol were markedly increased in the uremic serum compared with those in normal serum. Figure 4 shows negative-ion APCI mass spectra of phenol, p-cresol, and p-ethylphenol (internal standard). 
DIscussion
In uremic patients, phenol and p-cresol are markedly accumulated in the serum and are considered to be responsible for uremic coma and bleeding tendencies (1) (2) (3) (4) (5) (6) (7) (8) (9) . The uremic undialyzed patients with serum phenol concentrations of -100 pmo]JL showed uremic coma and gastrointestinal bleeding. Although the dialyzed patients showed increased phenol concentrations (maximum 60 rniol/L) and p-cresol (maximum 111 imol/L), the long-term effects of the increased concentrations of phenols on dialysis patients are not yet known. Phenol and p-cresol are also reported to be cocarcinogens for mouse skin (17) . An increase in malignancies, especially malignant renal tumors, is observed in dialyzed patients.
However, it is not known whether the increased concentrations of serum phenols in the dialyzed patients are responsible for the increase in malignancies, and further study is required to elucidate the long-term effects of these increases.
Phenol and p-cresol are synthesized by intestinal bacteria through 4-hydroxybenzoic acid and 4-hydroxyphenylacetic acid, respectively, from tyrosine (10) (11) (12) (13) .
Urinary phenols originate from bacteria in the small intestine (18) . Aerobic bacteria mainly produce phenol, whereas anaerobic bacteria produce p-cresol (10) (11) (12) (13) . Phenols accumulate in uremic serum as a result of decreased renal clearance (5, 6). Other phenols, such as catechol, hydroquunone, homocatechol, and 2-methoxyresorcinol, also accumulate in uremic serum (4), but their concentrations in uremic patients are much lower than those of phenol and p-cresol.
We have developed a simple and sensitive HPLC method for measuring phenol and p-cresol in uremic serum. Identification of phenol and p-cresol was confirmed by LC/MS. Because the method requires only simple extraction by ethyl acetate and does not require further dehydration, evaporation, and derivatization, the method is much simpler than (3-C (1) or GC/MS (4).
With fluorescence used for detection, the method is highly specific and sensitive for phenol and p-cresol, with no interfering peaks on the chromatogram. The specificity and sensitivity of the newly developed HPLC method are comparable with GC/MS, which we developed for quantification of phenols in uremic serum (4). The sensitivity of GC/MS was reported to be 1.06 mol/L (14). The fluorescence HPLC assay is able to monitor these concentrations and can be used to monitor phenol concentrations in plasma of patients treated with phenol in regional nerve blocks. However, the GC/MS method requires laborious sample preparation and expensive equipment are also reported to accumulate in uremic serum (4) . To quantify the conjugated phenols, one should treat the serum with sulfatase and (or) f3-glucuronidase before extraction. Because unconjugated phenols are more toxic than conjugated phenols, monitoring the unconjugated form in serum is clinically more important.
The reduction rates of phenol and p-cresol by hemodialysis were significantly lower than those of urea and With our method, serum concentrations of phenol and p-cresol can be easily and rapidly quantified. The newly developed HPLC method will be useful for monitoring serum phenols in dialyzed patients as an index of hemodialysis adequacy.
